DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Newsome PN, Fox R, King AL. et al.
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.
Lancet Gastroenterol Hepatol 2018;
3 (01) 25-36
We do not assume any responsibility for the contents of the web pages of other providers.